One in 3 Cancer Survivors Has Chronic Pain
A report by researchers from Mount Sinai, Memorial Sloan-Kettering Cancer Center, University of Virginia, and the American Cancer Society finds that about one-third of cancer survivors (34.6%) reported having chronic pain.
Many Cancer Survivors Struggle to Pay For Care
The population of cancer survivors in the US is growing, and many struggle to pay health care costs. A study led by the Centers for Disease Control and Prevention (CDC) finds one-fourth of survivors have problems paying medical bills and one-third worry about them.
FDA Approves Keytruda (Pembrolizumab) for Head and Neck Cancer
The US Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab) as a first-line treatment for people with advanced head and neck cancer.
FDA Approves Polivy (Polatuzumab Vedotin-piiq) for Lymphoma
The US Food and Drug Administration (FDA) has approved the antibody-drug conjugate Polivy (polatuzumab vedotin-piiq) to treat people with diffuse large B-cell lymphoma (DLBCL).
Population of US Cancer Survivors Grows to Nearly 17 Million
A new report by the American Cancer Society – in collaboration with the National Cancer Institute – estimates there are more than 16.9 million cancer survivors alive in the US today, and that number will grow to more than 22.1 million by 2030.